The results of this randomized, double-blind, placebo-controlled, forced-dose titration study in a diverse population of hypertensive patients in the US indicate that candesartan cilexetil has clinically meaningful dose-related blood pressure-lowering effects and that maximum blood pressure reduction is achieved with doses of 16 and 32 mg given once daily. This study confirms that candesartan cilexetil is a highly effective antihypertensive agent with an excellent tolerability and safety profile, without dose-related adverse effects.
机构:
Univ Glasgow, Western Infirm, Dept Med & Therapeut, Div Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, ScotlandUniv Glasgow, Western Infirm, Dept Med & Therapeut, Div Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland